These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 15937368

  • 1. Prevalence and spectrum of von Willebrand disease from western India.
    Trasi S, Shetty S, Ghosh K, Mohanty D.
    Indian J Med Res; 2005 May; 121(5):653-8. PubMed ID: 15937368
    [Abstract] [Full Text] [Related]

  • 2. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, Turecek PL, Lillicrap D, Rand ML.
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [Abstract] [Full Text] [Related]

  • 3. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z.
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [Abstract] [Full Text] [Related]

  • 4. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ, Gadisseur A, Budde U, Berneman Z, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [Abstract] [Full Text] [Related]

  • 5. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
    Kurth AA, Ludwig G, Scharrer I.
    Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and spectrum of von Willebrand disease in Eastern Uttar Pradesh.
    Kumar S, Kishore R, Gupta V, Jain M, Shukla J.
    Indian J Pathol Microbiol; 2010 Apr; 53(3):486-9. PubMed ID: 20699508
    [Abstract] [Full Text] [Related]

  • 7. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G, Vauterin S, Deckmyn H.
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [Abstract] [Full Text] [Related]

  • 8. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 Apr; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 9. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
    Frontroth JP, Hepner M, Sciuccati G, Feliú Torres A, Pieroni G, Bonduel M.
    Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
    [Abstract] [Full Text] [Related]

  • 10. Laboratory diagnosis of congenital von Willebrand disease.
    Budde U, Drewke E, Mainusch K, Schneppenheim R.
    Semin Thromb Hemost; 2002 Apr; 28(2):173-90. PubMed ID: 11992241
    [Abstract] [Full Text] [Related]

  • 11. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey.
    Favaloro EJ.
    Semin Thromb Hemost; 2002 Apr; 28(2):191-202. PubMed ID: 11992242
    [Abstract] [Full Text] [Related]

  • 12. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR, Strasser EF, Ringwald J, Zimmermann R, Eckstein R.
    Clin Lab; 2012 Apr; 58(11-12):1203-9. PubMed ID: 23289190
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology, diagnosis, and management of von Willebrand disease in India.
    Ghosh K, Shetty S.
    Semin Thromb Hemost; 2011 Jul; 37(5):595-601. PubMed ID: 22102205
    [Abstract] [Full Text] [Related]

  • 14. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A, van der Planken M, Schroyens W, Berneman Z, Michiels JJ.
    Acta Haematol; 2009 Jul; 121(2-3):145-53. PubMed ID: 19506361
    [Abstract] [Full Text] [Related]

  • 15. Multimeric analysis in diagnosis of vWD variants in Indians.
    Gupta PK, Kumar H, Saxena R.
    Indian J Pathol Microbiol; 2007 Jul; 50(3):636-9. PubMed ID: 17883169
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis and management of von Willebrand disease in Australia.
    Favaloro EJ, Bonar R, Favaloro J, Koutts J.
    Semin Thromb Hemost; 2011 Jul; 37(5):542-54. PubMed ID: 22102198
    [Abstract] [Full Text] [Related]

  • 17. Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders.
    Gupta PK, Charan VD, Saxena R.
    Ann Hematol; 2007 Jun; 86(6):403-7. PubMed ID: 17375300
    [Abstract] [Full Text] [Related]

  • 18. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H.
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.